Sensus Healthcare Inc Stock News

Biotech isn't the only place investors in health care stocks can make money in 2022. Take a look at leading medical-equipment stocks.

BOCA RATON, Fla., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effect

Axonics is breaking out from a three-weeks-tight pattern after announcing it has begin treating patients in Canada. The post Medical Device Maker Announces New Patients, Shoots Past Buy Point appeared

Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are SRTS, SMCI, ULH, ACA and CELH.

Sensus Healthcare announced strong Q2 FY2022 results with significant revenue and profit margin growth. The company is experiencing industrial tailwinds as skin cancer patients are continuously increa

Sensus Healthcare, Inc. (NASDAQ:SRTS ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Kim Golodetz - Senior Vice President and Principal, Lippert/Heilshorn & Associate

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 16.67% and 17.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Canada's national business paper, The Globe and Mail, recently interviewed a Toronto-based portfolio manager who seeks out smaller growth stocks with the potential to become large caps over the long h

Sensus Healthcare, Inc. (SRTS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in th

Investors need to pay close attention to Sensus Healthcare (SRTS) stock based on the movements in the options market lately.

BOCA RATON, Fla, May 23, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effecti

Sensus Healthcare, Inc. (SRTS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

BOCA RATON, Fla, May 23, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective

Sensus Healthcare, Inc. (SRTS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Sensus has developed an FDA-cleared laser device that targets non-melanoma skin cancers and keloids. While 2021 was a tough time for the company as elective procedures non-existent during the pandemic